Reliable biotechnology news today? BioTech Health X brings you the latest quality biotechnology news including breaking news on the latest biotechnology research, emerging companies, biotech acquisitions, funding deals and other industry analysis. Our coverage not only includes study news and site updates from researchers but also financial analysis of the high and low daily market including several of the last market moves, first opening market updates, top share tips and more. Get everything you need delivered straight to your Inbox with our newsletter based on the science research and stories you want to read and follow from our team. Sign up for free today!
The global nerve conduit market is estimated at around 150,000 units as of 2021 and has been growing at a rate of 15 percent per annum*1. The U.S. accounts for about 70 percent of the share, making it the biggest market of its kind in the world. Toyobo plans to feature the product in collaboration with Synovis at conferences held by various societies. At the events, the company plans to present data*2,3 on clinical tests, post-sale surveys and clinical practice it has accumulated since the company started marketing the product in Japan in 2013. The societies to which Toyobo will showcase the product are those holding conferences across the United States, including ASRM, ASSH and the American Society of Plastic Surgeons.
CureDuchenne, a company committed to finding a cure for Duchenne muscular dystrophy (DMD), will be holding its FUTURES 2022 conference in Orlando, Florida this May. CureDuchenne’s mission is to extend and improve the lives of everyone affected by Duchenne muscular dystrophy,” CEO Debra Miller told BioSpace. Duchenne is a fatal and progressive muscle wasting disease. It affects primarily boys, although girls can be carriers, so it really does affect the whole family. Miller explained that the boys who suffer are typically confined to a wheelchair by the age of 12. Our mission is to fund transformative and impactful research that stands a good chance of resulting in an approved drug, she continued. We also provide support and resources to the families that are living with this disease.
From expected trial results to explaining the mechanism of action, our system of news and research that we develop has led to BioTech Health X becoming leaders in the biotechnology news industry. Beginning with pre-clinical stage companies in development to communities sharing natural product research, our website has benefits all interested in learning about the latest in biotechnology from scientists and the importance of continued growth. Discover additional info on https://biotechhealthx.com/.
On the other hand, the Asia Pacific region is expected to undergo massive transformation in terms of the growth of the passive prosthetics market. With the growing incidences of physical disabilities due to accidents or mishaps, the region provides ample growth opportunities for the leading players in the market. Moreover, with the developments in the healthcare infrastructure of the emerging nations such as India and China, passive prosthetics market players are sensing lucrative business opportunities.
